151 related articles for article (PubMed ID: 7701581)
1. Ten years' experience of bone marrow transplantation for Gaucher disease.
Ringdén O; Groth CG; Erikson A; Granqvist S; Månsson JE; Sparrelid E
Transplantation; 1995 Mar; 59(6):864-70. PubMed ID: 7701581
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type.
Erikson A; Groth CG; Månsson JE; Percy A; Ringdén O; Svennerholm L
Acta Paediatr Scand; 1990; 79(6-7):680-5. PubMed ID: 2386062
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
Bradley BA; Hows JM; Gore SM; Bidwell JL; Clay T; Downie TR; Gluckman E; Howard MR; Laundy GJ
Clin Transpl; 1992; ():91-107. PubMed ID: 1306726
[TBL] [Abstract][Full Text] [Related]
5. Allogenic bone marrow transplantation in severe Gaucher disease.
Tsai P; Lipton JM; Sahdev I; Najfeld V; Rankin LR; Slyper AH; Ludman M; Grabowski GA
Pediatr Res; 1992 May; 31(5):503-7. PubMed ID: 1603628
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation for Gaucher disease--a case report.
Yen CC; Chiou TJ; Lin CY; Wang NH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):372-6. PubMed ID: 9294918
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
[TBL] [Abstract][Full Text] [Related]
8. Secondary G-CSF mobilized blood stem cell transplantation without preconditioning in a patient with Gaucher disease: Report of a new approach which resulted in complete reversal of severe skeletal involvement.
Yabe H; Yabe M; Hattori K; Inoue H; Matsumoto M; Hamanoue S; Hiroi A; Koike T; Kato S
Tokai J Exp Clin Med; 2005 Apr; 30(1):77-82. PubMed ID: 15952302
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease.
Ringdén O; Groth CG; Erikson A; Bäckman L; Granqvist S; Månsson JE; Svennerholm L
Transplantation; 1988 Jul; 46(1):66-70. PubMed ID: 3134756
[TBL] [Abstract][Full Text] [Related]
10. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group.
Peters C; Shapiro EG; Anderson J; Henslee-Downey PJ; Klemperer MR; Cowan MJ; Saunders EF; deAlarcon PA; Twist C; Nachman JB; Hale GA; Harris RE; Rozans MK; Kurtzberg J; Grayson GH; Williams TE; Lenarsky C; Wagner JE; Krivit W
Blood; 1998 Apr; 91(7):2601-8. PubMed ID: 9516162
[TBL] [Abstract][Full Text] [Related]
11. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
[TBL] [Abstract][Full Text] [Related]
12. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of short tandem repeats with fluorescence labeling polymerase chain reaction to document engraftment following allogeneic bone marrow transplantation].
Xiao L; Guo K; Chen H
Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):418-22. PubMed ID: 11718093
[TBL] [Abstract][Full Text] [Related]
15. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
[TBL] [Abstract][Full Text] [Related]
16. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
18. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
Chim CS; Lie AK; Liang R; Au WY; Kwong YL
Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
